SLS.NASDAQSellas Life Sciences Group, INC

Form 4: SELLAS CEO's RSU Tax Withholding Transaction Reported

Sentiment:

Insider Transaction Report

📋All filings for Sellas Life Sciences Group, INC
🔒Login to Follow

SELLAS Life Sciences Group CEO Angelos M. Stergiou reported a disposition of 187,066 common shares to cover tax obligations from RSU vesting.

Summary

  • Angelos M. Stergiou, President and CEO, and Director of SELLAS Life Sciences Group, Inc., reported a transaction on December 3, 2025.
  • 187,066 shares of common stock were disposed of by the Issuer to cover tax withholding obligations of Mr. Stergiou.
  • This disposition was in connection with the vesting of Restricted Stock Units (RSUs).
  • The shares were valued at a deemed price of $1.5 per share for tax withholding purposes.
  • Following this transaction, Mr. Stergiou directly beneficially owns 686,966 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral. This is a routine, non-discretionary transaction related to executive compensation and tax obligations, not indicative of discretionary buying or selling activity by the insider.

Positives

  • The underlying event, the vesting of Restricted Stock Units (RSUs), indicates the achievement of performance milestones or continued tenure by the CEO, reflecting a component of executive compensation.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction related to executive compensation, which is a standard practice across various industries and does not reflect broader industry trends or competitive positioning.

Related Party Transactions

  • Disposition of 187,066 common shares by SELLAS Life Sciences Group, Inc. (the Issuer) to cover tax withholding obligations for its President and CEO, Angelos M. Stergiou, in connection with RSU vesting.

Stakeholder Impact

  • Shareholders: The transaction is a routine part of executive compensation and does not represent a discretionary sale by the CEO. The underlying RSU vesting is a planned compensation event.
  • Management: The CEO realized compensation through the vesting of Restricted Stock Units, with a portion withheld for tax purposes.

Key Dates

DateDescription
12/03/2025Date of transaction where shares were withheld for tax obligations related to RSU vesting.
12/05/2025Date the Form 4 was signed by the Power of Attorney for Angelos M. Stergiou.

Recommendation

hold

This Form 4 reports a non-discretionary transaction where shares were withheld to cover tax obligations related to RSU vesting. It does not reflect a discretionary buy or sell decision by the insider and therefore does not provide new information that would alter an investment recommendation.

Keywords

SELLAS Life Sciences, SLS, Form 4, Insider Transaction, RSU, Restricted Stock Units, Tax Withholding, Angelos M. Stergiou, CEO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.